|
Volumn 42, Issue 3, 2009, Pages 152-154
|
Type 3 choroidal neovascularization associated with fundus flavimaculatus
|
Author keywords
Fundus flavimaculatus; Intravitreal ranibizumab; Lucentis, macular dystrophy; Retinal angiomatous proliferation; Spectral domain optical coherence tomography; Type 3 choroidal neovascularization
|
Indexed keywords
RANIBIZUMAB;
ABSENCE OF SIDE EFFECTS;
AGED;
ARTICLE;
CASE REPORT;
DISEASE ASSOCIATION;
EYE FUNDUS FLAVIMACULATUS;
FEMALE;
FLUORESCENCE ANGIOGRAPHY;
HUMAN;
INDOCYANINE GREEN ANGIOGRAPHY;
OPHTHALMOSCOPY;
OPTICAL COHERENCE TOMOGRAPHY;
PRIORITY JOURNAL;
RETINA DETACHMENT;
RETINA DISEASE;
RETINA MACULA HEMORRHAGE;
SUBRETINAL NEOVASCULARIZATION;
VISUAL ACUITY;
AGED;
ANTIBODIES, MONOCLONAL;
CHOROIDAL NEOVASCULARIZATION;
CICATRIX;
FEMALE;
FLUORESCEIN ANGIOGRAPHY;
FUNDUS OCULI;
HUMANS;
IMMUNOLOGIC FACTORS;
RETINAL DEGENERATION;
TOMOGRAPHY, OPTICAL COHERENCE;
TREATMENT OUTCOME;
VISUAL ACUITY;
|
EID: 67650996692
PISSN: 00303747
EISSN: None
Source Type: Journal
DOI: 10.1159/000229030 Document Type: Article |
Times cited : (11)
|
References (9)
|